The upregulation of MHC and co‐stimulatory molecules on myeloid cells, in conjunction with the release of pro‐inflammatory cytokines, serves as the initiation mechanism for GVHD during the early stages following allo‐HSCT [33, 34]. The gene discussed is HLA-C; the disease is graft versus host disease.